Activities of ABT-773 against Microaerophilic and Fastidious Organisms
AUTOR(ES)
Finegold, Sydney M.
FONTE
American Society for Microbiology
RESUMO
ABT-773 was tested against 317 fastidious isolates; it inhibited 99% of organisms at a concentration of 4.0 μg/ml. With ampicillin-sulbactam and levofloxacin, only 2 and 6% of these strains, respectively, were resistant at the breakpoint. With clindamycin, penicillin G, and metronidazole, 22, 26, and 58% of the strains, respectively, were resistant.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=127350Documentos Relacionados
- In Vitro Activities of ABT-773 and Other Antimicrobials against Human Mycoplasmas
- Activities of ABT-773 against Listeria monocytogenes and Coryneform Bacteria of Clinical Interest
- In Vitro Bactericidal Activities of ABT-773 against ermB Strains of Streptococcus pneumoniae
- Comparative In Vitro Activities of ABT-773 against 362 Clinical Isolates of Anaerobic Bacteria
- Comparison of In Vitro Activities of ABT-773 and Telithromycin against Macrolide-Susceptible and -Resistant Streptococci and Staphylococci
